Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography‐mass spectrometry and application to a pharmacokinetic study of levamisole. Issue 10 (20th February 2014)
- Record Type:
- Journal Article
- Title:
- Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography‐mass spectrometry and application to a pharmacokinetic study of levamisole. Issue 10 (20th February 2014)
- Main Title:
- Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography‐mass spectrometry and application to a pharmacokinetic study of levamisole
- Authors:
- Hess, Cornelius
Ritke, Natalie
Sydow, Konrad
Mehling, Lena‐Maria
Ruehs, Hauke
Madea, Burkhard
Musshoff, Frank - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Levamisole is an anti‐helminthic drug and gained forensic interest after it was found that it was used as a cocaine adulterant. A liquid chromatography‐mass spectrometry (LC‐MS) method for the determination of levamisole and its metabolite aminorex in human plasma is described. Selectivity is given; calibration curves were linear within a calibration range of 1 ng/mL–500 ng/mL. Limits of detection and quantification (LODs, LOQs) were 0.85 ng/mL for levamisole and 0.09 ng/mL, and 0.34 ng/mL for aminorex, respectively. Precision data was in accordance with the GTFCh guidelines. The validated method was successfully applied to study the pharmacokinetics of levamisole after administration of 100 mg of levamisole orally. Levamisole could be detected up to 36 h after ingestion in serum, while aminorex never exceeded the LOQ. A one‐compartment model best described levamisole pharmacokinetics. The following parameters were calculated: ka = 1.2 [1/h], CL/F = 52 l/h, V/F = 347 l, f (renal) = 0.0005, t ½ = 2.0 h, AUC = 1923 ng/mL*h, cmax = 214 ng/mL, tmax = 1.98 h. Levamisole could be quantified in 42.5% of cocaine – positive plasma samples (2.2 to 224 ng/mL). Aminorex was positive in only 11.3% of the cases; however, it was never found higher than the LOQ. Pemoline, another stimulant detected in horse urine samples after administration of levamisole, was not found either in serum or in urine of<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Levamisole is an anti‐helminthic drug and gained forensic interest after it was found that it was used as a cocaine adulterant. A liquid chromatography‐mass spectrometry (LC‐MS) method for the determination of levamisole and its metabolite aminorex in human plasma is described. Selectivity is given; calibration curves were linear within a calibration range of 1 ng/mL–500 ng/mL. Limits of detection and quantification (LODs, LOQs) were 0.85 ng/mL for levamisole and 0.09 ng/mL, and 0.34 ng/mL for aminorex, respectively. Precision data was in accordance with the GTFCh guidelines. The validated method was successfully applied to study the pharmacokinetics of levamisole after administration of 100 mg of levamisole orally. Levamisole could be detected up to 36 h after ingestion in serum, while aminorex never exceeded the LOQ. A one‐compartment model best described levamisole pharmacokinetics. The following parameters were calculated: ka = 1.2 [1/h], CL/F = 52 l/h, V/F = 347 l, f (renal) = 0.0005, t ½ = 2.0 h, AUC = 1923 ng/mL*h, cmax = 214 ng/mL, tmax = 1.98 h. Levamisole could be quantified in 42.5% of cocaine – positive plasma samples (2.2 to 224 ng/mL). Aminorex was positive in only 11.3% of the cases; however, it was never found higher than the LOQ. Pemoline, another stimulant detected in horse urine samples after administration of levamisole, was not found either in serum or in urine of this pharmacokinetic study. In post‐mortem cases, levamisole and aminorex could be detected in femoral blood and the urine of cocaine users. Pemoline was not detected. Copyright © 2014 John Wiley &amp; Sons, Ltd.</p> </abstract> … (more)
- Is Part Of:
- Drug testing and analysis. Volume 6:Issue 10(2014:Oct.)
- Journal:
- Drug testing and analysis
- Issue:
- Volume 6:Issue 10(2014:Oct.)
- Issue Display:
- Volume 6, Issue 10 (2014)
- Year:
- 2014
- Volume:
- 6
- Issue:
- 10
- Issue Sort Value:
- 2014-0006-0010-0000
- Page Start:
- 1049
- Page End:
- 1054
- Publication Date:
- 2014-02-20
- Subjects:
- Drugs -- Analysis -- Periodicals
Drug testing -- Periodicals
Chemistry, Forensic -- Periodicals
615.1901 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=110501 ↗
http://www3.interscience.wiley.com/journal/121408477/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/dta.1619 ↗
- Languages:
- English
- ISSNs:
- 1942-7603
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.424000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3475.xml